• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低年龄风险成年人中数字时钟绘图测试与淀粉样蛋白和tau蛋白PET生物标志物的关联。

Association of the digital clock drawing test with amyloid and tau PET biomarkers in low age risk adults.

作者信息

Ding Huitong, Lyu Chenglin, Karjadi Cody, Sunderaraman Preeti, Young Christina B, Mormino Elizabeth C, Low Spencer, Devine Sherral, Gifford Katherine, Au Rhoda, Lin Honghuang

机构信息

Department of Anatomy and Neurobiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.

The Framingham Heart Study, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.

出版信息

Sci Rep. 2025 Apr 1;15(1):11104. doi: 10.1038/s41598-025-95852-8.

DOI:10.1038/s41598-025-95852-8
PMID:40169870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11961701/
Abstract

Although brain amyloid and tau deposition measured by PET scans are established as biomarkers of Alzheimer's disease (AD), they can emerge decades before symptoms are detectable on traditional neuropsychological (NP) tests. There is a pressing need for early AD detection tools that are more accessible, cost-effective, and non-invasive. The digital clock drawing test (dCDT), a digital version of the clock drawing test, has emerged as a promising cognitive assessment tool that takes minutes to administer and can reveal clinical symptoms earlier than paper-pencil NP tests. This study explored the association between 53 dCDT measures and amyloid and tau PET biomarkers using data from 87 low age risk participants in the Framingham Heart Study. Our findings revealed a significant association between a dCDT measure related to spatial reasoning function and global amyloid burden (P < 0.05), and 4 dCDT measures correlated with tau accumulation after adjusting for multiple comparisons. Notably, the combination of demographic variables and a composite dCDT score achieved a mean area under the receiver operating characteristics curve of 0.86 in detecting amyloid positivity. These results highlight the potential of dCDT measures as effective predictors of amyloid and tau pathology in preclinical AD.

摘要

尽管通过PET扫描测量的脑淀粉样蛋白和tau蛋白沉积已被确立为阿尔茨海默病(AD)的生物标志物,但它们可能在传统神经心理学(NP)测试可检测到症状的数十年前就已出现。迫切需要更易获得、成本效益更高且非侵入性的早期AD检测工具。数字时钟绘图测试(dCDT)是时钟绘图测试的数字版本,已成为一种很有前景的认知评估工具,只需几分钟即可完成,并且比纸笔NP测试能更早地揭示临床症状。本研究利用弗雷明汉心脏研究中87名低年龄风险参与者的数据,探讨了53项dCDT测量指标与淀粉样蛋白和tau蛋白PET生物标志物之间的关联。我们的研究结果显示,一项与空间推理功能相关的dCDT测量指标与整体淀粉样蛋白负荷之间存在显著关联(P < 0.05),并且在进行多重比较校正后,有4项dCDT测量指标与tau蛋白积累相关。值得注意的是,人口统计学变量和综合dCDT评分的组合在检测淀粉样蛋白阳性方面,受试者操作特征曲线下的平均面积达到了0.86。这些结果凸显了dCDT测量指标作为临床前AD中淀粉样蛋白和tau蛋白病理学有效预测指标的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09bb/11961701/15d2cb264105/41598_2025_95852_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09bb/11961701/15d2cb264105/41598_2025_95852_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09bb/11961701/15d2cb264105/41598_2025_95852_Fig1_HTML.jpg

相似文献

1
Association of the digital clock drawing test with amyloid and tau PET biomarkers in low age risk adults.低年龄风险成年人中数字时钟绘图测试与淀粉样蛋白和tau蛋白PET生物标志物的关联。
Sci Rep. 2025 Apr 1;15(1):11104. doi: 10.1038/s41598-025-95852-8.
2
Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults.正常老年人的数字时钟绘画与 PET 淀粉样蛋白和 Tau 病理学的关联。
Neurology. 2021 Apr 6;96(14):e1844-e1854. doi: 10.1212/WNL.0000000000011697. Epub 2021 Feb 15.
3
Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.描述阿尔茨海默病中淀粉样蛋白时间线上的脑 tau 与认知衰退。
Brain. 2024 Jun 3;147(6):2144-2157. doi: 10.1093/brain/awae116.
4
Associations Between the Digital Clock Drawing Test and Brain Volume: Large Community-Based Prospective Cohort (Framingham Heart Study).数字时钟绘画测试与脑容量的关联:大型社区前瞻性队列研究(弗雷明汉心脏研究)。
J Med Internet Res. 2022 Apr 15;24(4):e34513. doi: 10.2196/34513.
5
Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.使用脑脊液磷酸化tau 和 AV1451 正电子发射断层扫描技术对阿尔茨海默病生物标志物差异进行特征分析。
JAMA Neurol. 2020 Apr 1;77(4):508-516. doi: 10.1001/jamaneurol.2019.4749.
6
Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.常染色体显性遗传阿尔茨海默病患者中淀粉样蛋白和tau 蛋白蓄积的相关性。
JAMA Neurol. 2018 May 1;75(5):548-556. doi: 10.1001/jamaneurol.2017.4907.
7
Classifying Non-Dementia and Alzheimer's Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test.基于运动学、时间和视空间参数对非痴呆和阿尔茨海默病/血管性痴呆患者进行分类:数字钟画测试。
J Alzheimers Dis. 2021;82(1):47-57. doi: 10.3233/JAD-201129.
8
Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults.血液磷酸化 tau181 作为认知健康成年人脑 PET 淀粉样蛋白负担的生物标志物。
J Alzheimers Dis. 2022;87(4):1517-1526. doi: 10.3233/JAD-215639.
9
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.比较多种 tau-PET 指标作为衰老和阿尔茨海默病的生物标志物。
Neuroimage. 2017 Aug 15;157:448-463. doi: 10.1016/j.neuroimage.2017.05.058. Epub 2017 Jun 3.
10
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.tau蛋白病变和神经退行性变导致阿尔茨海默病的认知障碍。
Brain. 2017 Dec 1;140(12):3286-3300. doi: 10.1093/brain/awx243.

本文引用的文献

1
Prediction of Progression from Mild Cognitive Impairment to Alzheimer's disease with Longitudinal and Multimodal Data.利用纵向和多模态数据预测轻度认知障碍向阿尔茨海默病的进展
Front Dement. 2023;2. doi: 10.3389/frdem.2023.1271680. Epub 2023 Nov 24.
2
Speech patterns during memory recall relates to early tau burden across adulthood.记忆回放期间的言语模式与整个成年期早期的 tau 负担有关。
Alzheimers Dement. 2024 Apr;20(4):2552-2563. doi: 10.1002/alz.13731. Epub 2024 Feb 13.
3
Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults.
数字时钟绘画作为阿尔茨海默病易感性生物标志物:与老年人遗传风险评分和载脂蛋白E的关联
J Prev Alzheimers Dis. 2024;11(1):79-87. doi: 10.14283/jpad.2023.48.
4
Using digital assessment technology to detect neuropsychological problems in primary care settings.在初级保健环境中使用数字评估技术来检测神经心理问题。
Front Psychol. 2023 Nov 17;14:1280593. doi: 10.3389/fpsyg.2023.1280593. eCollection 2023.
5
Maximizing utility of neuropsychological measures in sex-specific predictive models of incident Alzheimer's disease in the Framingham Heart Study.最大化神经心理学测量在弗雷明汉心脏研究中性别特异性阿尔茨海默病发病预测模型中的效用。
Alzheimers Dement. 2024 Feb;20(2):1112-1122. doi: 10.1002/alz.13500. Epub 2023 Oct 26.
6
Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study.多模态机器学习在 10 年痴呆风险预测中的应用:弗雷明汉心脏研究。
J Alzheimers Dis. 2023;96(1):277-286. doi: 10.3233/JAD-230496.
7
Trial of Solanezumab in Preclinical Alzheimer's Disease.在临床前阿尔茨海默病中进行的 Solanezumab 试验。
N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17.
8
Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases.多种散发性神经退行性疾病的诊断前认知和功能障碍。
Alzheimers Dement. 2023 May;19(5):1752-1763. doi: 10.1002/alz.12802. Epub 2022 Oct 12.
9
Association of Aortic Stiffness and Pressure Pulsatility With Global Amyloid-β and Regional Tau Burden Among Framingham Heart Study Participants Without Dementia.弗雷明汉心脏研究参与者中无痴呆症人群的主动脉僵硬和压力脉动与全脑β淀粉样蛋白和局部 tau 负荷的相关性。
JAMA Neurol. 2022 Jul 1;79(7):710-719. doi: 10.1001/jamaneurol.2022.1261.
10
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.阿尔茨海默病中的 Tau 生物标志物:迈向临床实践和试验的应用。
Lancet Neurol. 2022 Aug;21(8):726-734. doi: 10.1016/S1474-4422(22)00168-5. Epub 2022 May 25.